4Hedinger C,Williams ED, Sobin LH. The WHO histological classification ofthyroidumors:a commentary on the second edition [ J ]. Cancer, 1989,63 ( 3 ) :908-911.
5Guidelines sub-committee. Guideline for europear society of management of hypertension [ J ]. J Hypertension, 2003,21 : 1011.
6Benson SC, Pershadsingh HA, Ho CI, et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR-γ-modulating activity [ J ]. Hypertension, 2004, 43(5) : 993-1002.
7Schupp M, Janke J, Clasen R, et al. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity [ J]. Circulation, 2004, 109 ( 17 ) : 2054 -2057.
8Coel J M, Neutel MD, Dvid HG, et al. Evaluation of angiotensin II receptor blockers for 24-hour blood pressurecontrol : meta-analysis of a clinical database [ J ]. J Clin Hypertens , 2003,5( 1 ) :58-63.
9Wu X, Sallinen K,Anttila L, et al. Expression of insulin-receptor substrate-1 and-2 in ovaries from women with insulin resistance and from controls [ J ]. FertilSteri, 2000,74 (3) : 56.
10Navookarasu NT, Rahman AR, Abdullah I, et al. First-dose response to angiotensin converting enzyme inhibition in congestive cardiac failure: a Malaysian experience. Int J Clin Pract, 1999,53:25-30.
